A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group - Buzdar,A.U.; Jones,S.E.; Vogel,C.L.; Wolter,J.; Plourde,P.; Webster,A. (Cancer, 1997)